Leonabio Inc (LONA)

07:44 AM

Mizuho raises LeonaBio stock price target to $16 on breast cancer drug outlook - Investing.com India

07:44 AM

06:39 AM

Mizuho Raises Price Target on LeonaBio to $16 From $10, Keeps Outperform Rating - marketscreener.com

06:39 AM

Apr 02, 2026

Leonabio Warns of Major Financial and Operational Risks in Lasofoxifene Program Integration - tipranks.com

Apr 02, 2026

Apr 02, 2026

[EFFECT] LeonaBio, Inc. SEC Filing - Stock Titan

Apr 02, 2026

Apr 01, 2026

LeonaBio (NASDAQ: ATHA) registers 58.5M shares; warrants could yield $146M - Stock Titan

Apr 01, 2026

Mar 31, 2026

LeonaBio (ATHA) clears resale of 5.5M warrant shares for Sermonix - Stock Titan

Mar 31, 2026

Mar 31, 2026

LeonaBio (NASDAQ: LONA) files resale registration for PIPE warrant holders - Stock Titan

Mar 31, 2026

Mar 31, 2026

LeonaBio (NASDAQ: ATHA) leans on breast cancer and ALS drugs - Stock Titan

Mar 31, 2026

Mar 31, 2026

LeonaBio (NASDAQ: ATHA) expands Sermonix deal disclosure and ELAINE-3 trial spend - Stock Titan

Mar 31, 2026

Mar 27, 2026

LeonaBio Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2026

Mar 27, 2026

LeonaBio Reports 2025 Financial Results, Acquires Lasofoxifene License, and Advances Clinical Pipeline for Metastatic Breast Cancer and ALS 123 - Minichart

Mar 27, 2026

Mar 26, 2026

LeonaBio Updates Investors on 2025 Results and Strategy - TipRanks

Mar 26, 2026

Mar 26, 2026

LeonaBio (NASDAQ: LONA) boosts cash to fund Phase 3 breast cancer drug - Stock Titan

Mar 26, 2026

Mar 26, 2026

LeonaBio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 26, 2026

Mar 25, 2026

LeonaBio, Inc. announced that it has received $89.724073 million in funding - MarketScreener

Mar 25, 2026

Mar 25, 2026

LeonaBio (LONA) Stock Analysis Report | Financials & Insights - Benzinga Japan

Mar 25, 2026

Mar 20, 2026

LeonaBio, Inc. Adopts 2026 Equity Incentive Plan and Amends Certificate of Incorporation – SEC 8-K Filing March 2026 - Minichart

Mar 20, 2026

Mar 19, 2026

LeonaBio shareholders approve equity plan and increase in authorized shares - Investing.com India

Mar 19, 2026

Mar 19, 2026

Form 8K LeonaBio Inc For: 19 March - Investing.com

Mar 19, 2026

Mar 19, 2026

LeonaBio Expands Share Authorization to Support Future Financing - TipRanks

Mar 19, 2026

Mar 19, 2026

LeonaBio (ATHA) wins approval for 2026 equity plan and major share increase - Stock Titan

Mar 19, 2026

Mar 19, 2026

LONA: LeonaBio, Inc.Options Chain - Zacks Investment Research

Mar 19, 2026

Mar 13, 2026

LeonaBio, Inc. (prev. ATHA) (LONA) Stock Price Prediction for 2026, 2030-2040 - Traders Union

Mar 13, 2026

Mar 11, 2026

[DEFR14A] LeonaBio, Inc. Revised Proxy Statement - Stock Titan

Mar 11, 2026

Mar 10, 2026

Renninger, LeonaBio CFO, sells $4.9k in LONA stock - Investing.com Nigeria

Mar 10, 2026

Mar 06, 2026

LeonaBio CEO Litton sells $27,687 in shares By Investing.com - Investing.com India

Mar 06, 2026

Mar 05, 2026

LeonaBio CEO Litton sells $27,687 in shares - Investing.com South Africa

Mar 05, 2026

Mar 05, 2026

Renninger, LeonaBio CFO, sells $4.9k in LONA stock By Investing.com - Investing.com Canada

Mar 05, 2026

Mar 05, 2026

LeonaBio (ATHA) counsel sells 1,328 shares to cover RSU tax bill - Stock Titan

Mar 05, 2026

Mar 05, 2026

LeonaBio (LONA) CMO covers RSU tax bill with share sale - Stock Titan

Mar 05, 2026

Mar 05, 2026

LeonaBio (LONA) CSO exercises 5,856 RSUs and sells shares for taxes - Stock Titan

Mar 05, 2026

Mar 04, 2026

LeonaBio (NASDAQ: ATHA) files to sell 22,254 shares after RSU lapse - Stock Titan

Mar 04, 2026

Mar 02, 2026

Athira Pharma (LONA) 10K Form and SEC Filings 2026 $LONA - MarketBeat

Mar 02, 2026

Feb 26, 2026

Cantor Fitzgerald initiates Leona Bio stock with overweight rating By Investing.com - Investing.com Australia

Feb 26, 2026

Feb 26, 2026

LeonaBio initiated with an Overweight at Cantor Fitzgerald - TipRanks

Feb 26, 2026

Feb 26, 2026

Cantor Fitzgerald Initiates Coverage on LeonaBio With Overweight Rating - marketscreener.com

Feb 26, 2026

Feb 26, 2026

Cantor Fitzgerald initiates Leona Bio stock with overweight rating - Investing.com UK

Feb 26, 2026

Feb 25, 2026

LONA Technical Analysis & Stock Price Forecast - Intellectia AI

Feb 25, 2026

Feb 24, 2026

LONA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 24, 2026

Feb 23, 2026

LeonaBio Inc expected to post a loss of 85 cents a shareEarnings Preview - TradingView

Feb 23, 2026

Feb 21, 2026

LeonaBio, Inc. (prev. ATHA) (LONA) Stock Price Today | Live Chart & News - Traders Union

Feb 21, 2026

Feb 19, 2026

LeonaBio Shares Rise After Mizuho Securities Upgrade - marketscreener.com

Feb 19, 2026

Feb 19, 2026

LeonaBio (LONA) Receives Upgrade to Outperform by Mizuho | LONA Stock News - GuruFocus

Feb 19, 2026

Feb 19, 2026

Mizuho upgrades LeonaBio stock rating on breast cancer drug potential By Investing.com - Investing.com South Africa

Feb 19, 2026

Feb 18, 2026

Mizuho upgrades LeonaBio stock rating on breast cancer drug potential - Investing.com

Feb 18, 2026

Feb 18, 2026

Mizuho Securities Initiates LeonaBio(LONA.US) With Buy Rating, Announces Target Price $10 - 富途牛牛

Feb 18, 2026